Partial non‐adherence to antidiabetic therapy undermines diabetes management and correlates with treatment complexity: A cross‐sectional study using blood plasma analysis

Documenti analoghi

• Medication Adherence in Type 2 Diabetes: A Study Using Direct Blood Analysis
  di: Škop, Vojtěch, et al.
  Pubblicazione: (2026)
• Insulin therapy DE ‐ intensificAtion with iGlarLixi : A phase 4, open‐label, parallel‐group randomised controlled trial
  di: Peter Novodvorský, et al.
  Pubblicazione: (2025)
• Untargeted Metabolomics Identifies N‐Lactoyl‐Amino Acids as Dose‐Responsive Plasma Biomarkers of Metformin Adherence in Type 2 Diabetes
  di: Tomas Cajka, et al.
  Pubblicazione: (2026)
• Practical limitations of complex insulin therapies in type 2 diabetes: Focus on therapy simplification using fixed‐ratio combinations of basal insulin and a glucagon‐like peptide‐1 receptor agonist
  di: Luděk Horváth, et al.
  Pubblicazione: (2025)
• Time‐in‐range derived from self‐measured blood glucose in people with type 2 diabetes advancing to iGlarLixi : A participant‐level pooled analysis of three phase 3 LixiLan randomized controlled trials
  di: Martin Haluzík, et al.
  Pubblicazione: (2024)